2024 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2024 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2023 |
Morphosys AG - ADR
|
Member of the Supervisory Board |
- |
- |
2023 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2022 |
Morphosys AG - ADR
|
Member of the Supervisory Board |
40.6 K |
- |
2022 |
Arbutus Biopharma Corp
|
Independent Director |
30.9 K |
-68.1 % |
2022 |
Arbutus Biopharma Corp
|
Independent Director |
- |
- |
2022 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2022 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2021 |
Arbutus Biopharma Corp
|
Independent Director |
97.0 K |
14.8 % |
2021 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
94.3 K |
-31.6 % |
2021 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2020 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
138.0 K |
- |
2020 |
Arbutus Biopharma Corp
|
Independent Director |
84.5 K |
3.8 % |
2020 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2019 |
Arbutus Biopharma Corp
|
Independent Director |
81.4 K |
- |
2019 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2018 |
Akero Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |